Gene · 26871
RNU1-1: RNA, U1 small nuclear 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RNU1-1: RNA, U1 small nuclear 1. Genes, record 26871. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/26871
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants612
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RNU1-1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA014051 | Cancer Center Support (Core) Grant | 6 | 2025 |
| R01GM042699 | Biochemistry of Pre-mRNA Splicing | 5 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| R37AR040072 | Immune Responses in Lupus | 4 | 2025 |
| P50CA168504 | Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer | 2 | 2025 |
| R01DK063973 | Gene Transfer and NMR Studies in Alpha-Mannosidosis Brain | 2 | 2025 |
| R35GM136261 | Biochemical Mechanisms of Eukaryotic RNA Processing | 2 | 2025 |
| T32AI007533 | Training in Molecular Virology, Viral Pathogenesis and Viral Vectors | 2 | 2025 |
| T32AR007107 | Training Program in Investigative Rheumatology | 2 | 2025 |
1 to 10 of 612Source NIH's project files
See all 612 nih grantsPapers1,946
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A human-derived Pseudorabies virus isolate induces Cav2.2-sensitive Ca2+ influx and JNK-associated retinal epithelial injury. | Microbiol Spectr | 2026 | 42461027 | PubTator, text mining | PubMed |
| Identification and experimental validation of mitochondria pathway related genes in acute myeloid leukemia. | Front Immunol | 2026 | 42238582 | PubTator, text mining | PubMed |
| Dual-target antioxidant potential of benzimidazole-based thiazine and N-tosylated analogues: computational insights into human 11β-HSD1 and Leishmania GSK-3α inhibition. | Comput Biol Med | 2026 | 42061289 | PubTator, text mining | PubMed |
| Identification of suicide brain transcriptomic signatures using meta-analysis of multiple cohorts. | Transl Psychiatry | 2026 | 41916959 | PubTator, text mining | PubMed |
| Minor spliceosome inhibition via ablation of its U11 snRNA gene results in multiple defects in murine spermatogenesis. | Nucleic Acids Res | 2026 | 41736550 | PubTator, text mining | PubMed |
| The effect of walnut consumption on the peripheral blood mononuclear cell transcriptome. | Genes Nutr | 2026 | 41654725 | PubTator, text mining | PubMed |
| Chronic stress: a fourth etiology in tumorigenesis? | Mol Cancer | 2025 | 40676620 | PubTator, text mining | PubMed |
| Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia. | Sci Rep | 2024 | 39488607 | PubTator, text mining | PubMed |
| Flavonoid Rutin Presented Anti-Glioblastoma Activity Related to the Modulation of Onco miRNA-125b Expression and STAT3 Signaling and Impact on Microglia Inflammatory Profile. | Brain Sci | 2024 | 38248305 | PubTator, text mining | PubMed |
| Examining the capacity of human U1 snRNA variants to facilitate pre-mRNA splicing. | RNA | 2024 | 38164604 | PubTator, text mining | PubMed |
1 to 10 of 1,946
See all 1,946 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/26871
GET https://conductscience.org/api/genes/v1/26871/grants?page=2